137 related articles for article (PubMed ID: 1387023)
21. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys.
Seymour AA; Abboa-Offei B; Asaad MM; Rogers WL
Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819
[TBL] [Abstract][Full Text] [Related]
23. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
24. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
Trapani AJ; Beil ME; Bruseo CW; Savage P; Firooznia F; Jeng AY
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
Margulies KB; Perrella MA; McKinley LJ; Burnett JC
J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
[TBL] [Abstract][Full Text] [Related]
26. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys.
Seymour AA; Asaad MM; Abboa-Offei B; Smith PL; Rogers WL
Clin Exp Pharmacol Physiol; 1994 Nov; 21(11):845-56. PubMed ID: 7882575
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition.
Valentin JP; Qiu CB; Wiedemann E; Gardner D; Humphreys MH
Am J Hypertens; 1992 Feb; 5(2):88-91. PubMed ID: 1532317
[TBL] [Abstract][Full Text] [Related]
28. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors.
Seymour AA; Mathers PD; Abboa-Offei BE; Asaad MM; Weber H
J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase.
Seymour AA; Swerdel JN; Fennell SA; Druckman SP; Neubeck R; Delaney NG
J Cardiovasc Pharmacol; 1989 Aug; 14(2):194-204. PubMed ID: 2476591
[TBL] [Abstract][Full Text] [Related]
30. Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats.
Trippodo NC; Gabel RA; Harvey CM; Asaad MM; Rogers WL
J Cardiovasc Pharmacol; 1991 Sep; 18(3):308-16. PubMed ID: 1720829
[TBL] [Abstract][Full Text] [Related]
31. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
Jeng AY; Savage P; Beil ME; Bruseo CW; Hoyer D; Fink CA; Trapani AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064
[TBL] [Abstract][Full Text] [Related]
32. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR
J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.
Seymour AA; Fennell SA; Swerdel JN
Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
35. Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin.
Bachelard H; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 Jan; 105(1):202-10. PubMed ID: 1375856
[TBL] [Abstract][Full Text] [Related]
36. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
Fournié-Zaluski MC; Gonzalez W; Turcaud S; Pham I; Roques BP; Michel JB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4072-6. PubMed ID: 8171037
[TBL] [Abstract][Full Text] [Related]
37. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
38. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Trippodo NC; Fox M; Natarajan V; Panchal BC; Dorso CR; Asaad MM
J Pharmacol Exp Ther; 1993 Oct; 267(1):108-16. PubMed ID: 8229737
[TBL] [Abstract][Full Text] [Related]
39. Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin.
Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1990 May; 100(1):158-62. PubMed ID: 2196965
[TBL] [Abstract][Full Text] [Related]
40. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat.
Fozard JR; Part ML
Eur J Pharmacol; 1990 May; 180(1):153-9. PubMed ID: 2142091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
